Can gut dysbiosis, immune activation, and impaired bile emulsification reinforce one another?

The gut-liver-microbiome axis represents a highly integrated system where microbial metabolic activity directly influences host digestive efficiency and mucosal barrier integrity.

Mechanistic pathways of digestive impairment

• Bacterial deconjugation: Gut dysbiosis, such as small intestinal bacterial overgrowth (SIBO) involving shifts in genera like Lactobacillus, leads to elevated expression of microbial bile salt hydrolase (BSH) enzymes.
• Impaired emulsification: These BSH enzymes prematurely deconjugate bile acids, depleting the conjugated bile salt pool required for micelle formation and lipid emulsification.
• Malabsorption: Without proper emulsification, pancreatic lipase efficiency is significantly reduced, decreasing triglyceride digestion and increasing fecal lipid excretion, clinically manifesting as steatorrhea.

Mucosal irritation and immune feedback loops

• Epithelial damage: The accumulation of free hydrophobic, deconjugated bile acids exerts direct detergent-like cytotoxic effects on enterocytes, causing tight junction disruption and mucosal irritation.
• Immune activation: This barrier damage triggers mucosal immune activation, prompting a compensatory rise in secretory IgA (sIgA) to manage mucosal stress and inflammation.
• Sustained dysbiosis: Elevated sIgA selectively coats, excludes, and shapes specific bacterial taxa, establishing a pathological feedback loop that reinforces the initial dysbiosis and perpetuates the cycle of metabolic and digestive dysfunction.

Bottom line

• Gut dysbiosis, impaired lipid emulsification, and mucosal immune activation form a self-reinforcing pathological loop where premature bacterial bile acid deconjugation simultaneously impairs triglyceride digestion and generates cytotoxic free bile acids that damage the gut barrier, triggering immune responses that sustain the dysbiosis.